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Summary  
Vesicular stomatitis virus (VSV), the prototypic rhabdovirus, has been used as an excellent 
paradigm for understanding the mechanisms of virus replication, pathogenesis, host 
response to virus infection and also for myriads of studies on cellular and molecular 
biology. Biochemical studies as well as high-throughput genomics, proteomics, and 
chemical approaches have revealed a plethora of cellular factors and pathways that regulate 
replication of VSV. These factors include those that support virus replication and also those 
that restrict its replication. This chapter discusses the role(s) of many of these host cell 
factors and pathways involved in VSV replication. Although mechanistic understanding 
of the roles of some of these factors in VSV replication has been obtained, the roles of many 
others need to be investigated for a better understanding of the virus-host cell interactions.
 
Introduction 
Vesicular stomatitis virus (VSV) is an enveloped, non-segmented negative stranded (NNS) 
RNA virus in the family Rhabdoviridae and order Mononegavirales. Members of the family 
have been classified into eleven genera primarily based on antigenicity and phylogenetic 
analyses.
1 
Among them, the vesiculoviruses (prototype: VSV) and the lyssaviruses 
[prototype: rabies virus (RABV)] are the best characterized. Novel and emerging 
rhabdoviruses are continuously being identified and characterized (see chapter 13), many 
of which are yet to be classified due to lack of genome sequence information and low 
number of identified representative viruses in serogroups. 
The two known serotypes of VSV [Indiana (VSVI) and New Jersey (VSVNJ)] share 
many similar properties although differences have been reported.
2 
VSVI is the most well 
characterized serotype. Its negative- sense RNA genome encodes 5 major proteins: the 
nucleocapsid protein (N), the phosphoprotein (P), the matrix (M), the glycoprotein (G) and 
the large polymerase protein (L). Inside the virion, the viral genome is tightly encapsidated 
with the N protein to form ribonucleocapsid complex (RNP or NC) with which the viral 
RNA dependent RNA polymerase (RdRp) complex of P-L proteins is associated. The G 
protein forms spikes on the surface of VSV virions and is responsible for attachment to host 
cells. Both M and G proteins are required for assembly and budding of infectious particles. 
Following entry by endocytosis, the G protein mediates fusion of the viral envelope with 
the endosomal membrane, thereby releasing the viral RNP into the cytoplasm. The RNP 
undergoes primary transcription by the associated RdRp to produce five capped and 
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polyadenylated mRNAs, which are translated by the cellular translation machinery to 
generate the viral proteins for further steps in the infection process including genome 
replication, secondary transcription, virus assembly, and budding.
3 
VSV has been used as a workhorse for studying virus replication mechanisms, 
pathogenesis, evolution, and virus-host interactions as well as understanding many aspects 
of cellular and molecular biology. With the development of the reverse genetics system in 
the early 1990’s using a defective interfering (DI) particle of VSV,
4 
recovery of infectious 
RABV and VSV soon followed.
5-7 
Manipulation of full-length viral genomes and recovery 
of infectious viruses encoding a variety of foreign proteins have resulted in the use of these 
“designer viruses” as vaccine vectors (see chapter 9), as cancer therapeutics (chapter 10), 
and for myriads of studies on molecular and cellular biology of virus replication (chapters 
3, 5, and 8) and pathogenic mechanisms (chapters 7 and 15). 
Since VSV has been widely recognized as a valuable research tool with promising 
applications, recent efforts have focused on understanding its interaction with host cells 
by identification of crucial host factors using high throughput genomics, proteomics, and 
chemical approaches. This chapter describes our current understanding of the role(s) of 
the host functions in VSV replication, with a focus on recent findings on the cellular factors 
and pathways that regulate various steps in the viral life cycle. 
Host Functions Involved in Early Stages of VSV Infection 
Attachment 
Although VSV has been studied for over four decades, the key cellular factor(s) driving its 
pantropism has not been unequivocally identified. The low density lipoproteins (LDLs)
8 
and the phospholipids,
9-11 
in particular, phosphatidylserine (PS)
10 
were described as 
molecules responsible for VSV attachment to host cells. Subsequent studies revealed that 
PS is unlikely to serve such a role,
12 
although it may be involved in a post-binding steps of 
virus entry. Since the extent of G protein conformational change depends on the presence 
of PS on the target membrane and the rate of fusion reaction was remarkably increased 
when the PS content was increased,
13 
the function of PS in VSV infection process may 
likely be to support a fusion step during the uncoating of viral RNPs. Other membrane 
lipids, like sialoglycolipids (gangliosides) but not asialoglycolipids (cerebrosides) were also 
implicated in the virus attachment to host cells.
14,15 
However, a recent study has identified 
the LDL receptor (LDLR) as the major receptor and other LDLR family members, as the 
alternative receptors for VSV entry.
16 
LDLR family members are ubiquitously expressed 
in all cells and tissues across the animal kingdom and their specific interaction with the G 
protein may account for the pantropism of VSV.
16 
In addition, VSV binding to the target membrane may further depend on electrostatic 
interactions between positive charges on the G protein and negatively charged 
phospholipids in the cellular membranes.
13,17 
 The observation that removal of negatively 
charged polar head groups from these lipid molecules significantly reduces VSV attachment 
and fusion while the presence of polycation DEAE-dextran enhances VSV entry
18,19 
further 
strengthens this contention. The observed requirement for the endoplasmic reticulum (ER) 
chaperone gp96, a component of the multiprotein complex required for protein folding in 
the ER, in VSV binding to cells
20 
is likely to be indirect, as it is involved in glycosylation of 
LDLR.
16 
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Entry and NC Release 
The attached VSV virion is internalized by receptor-mediated endocytosis in clathrin coated 
vesicles
21-23 
in a dynamin-2-dependent manner.
24 
Since the average size of VSV (200nm 
long) is significantly larger than the dimensions of typical clathrin-coated pits, the vesicles 
used for clathrin-mediated endocytosis (CME) of VSV are not fully coated with clathrin 
and require actin polymerization for efficient internalization.
22 
However, endocytosis of 
smaller VSV particles, such as the defective interfering (DI-T) particles (75nm long) does 
not necessitate actin assembly.
23 
VSV G protein is responsible for both virus attachment 
and uncoating of viral RNP into the cytosol in a RAB5- dependent manner.
25 
RhoB and 
RhoC members of the Rho GTPase family which regulate many cellular aspects such 
as actin dynamics, cell proliferation, apoptosis, and gene expression
26 
also modulate 
VSV entry.
27 
Phosphorylation by cellular kinases is necessary for VSV entry as has been 
demonstrated by the use of kinase inhibitors
28 
and kinome siRNA screen.
29 
Okadaic acid, a 
serine/threonine phosphatase inhibitor, inhibits viral penetration and uncoating.
28 
Elegant 
studies to identify kinases involved in endocytic pathways revealed at least 48 kinases that 
act at different stages of endocytic pathway to be required for VSV entry by CME.
29 
Among 
them, kinases involved in cytoskeleton-dependent transport, G-protein receptor-linked 
kinases and kinases that regulate the mammalian target of rapamycin (mTOR)-dependent 
signaling and the Wnt/β-catenin signaling were identified.
29 
Mechanistic understanding 
of the role(s) of these kinases and pathways in VSV entry warrants further investigation. 
Following endocytic entry, VSV uncoating involves low pH dependent conformational 
change in G protein to induce fusion of viral envelope with the membrane of internal 
vesicles present in the multivesicular bodies (MVBs) inside the endosomes followed by a 
back- fusion of these internal vesicles with the limiting membrane of the late endosomes to 
release viral RNP into the cytoplasm
30 
(see chapter 3 for further details). Using fluorescent 
VSVs, studies show that the release of the viral RNPs into the cytoplasm occurs within 20-
30 min after binding of the virus to the host cell plasma membrane.
25,31 
The RNP release 
depends on the lipid lysobisphosphatidic acid (LBPA), which is only found in the late 
endosomes and its putative effector, ALG-2-interacting protein 1 (AIP1/ALIX), and are 
regulated by phosphatidylinositol-3- phosphate.
30 
Recent studies show that interaction 
of LBPA with ALIX is required for RNP release.
32 
LBPA was also recently shown to 
preferentially influence the ability of VSV G to mediate lipid mixing during membrane 
fusion.
33,34 
Depletion of several subunits of the endosomal sorting complex required for 
transport (ESCRT) pathway results in inhibition of VSV RNA synthesis during infection,
30,32 
suggesting that components of the ESCRT machinery are also required for the release of 
the viral RNPs into the cytoplasm from the endosomes. 
Host Functions in Viral Macromolecular Synthesis 
Viral mRNA Transcription 
After release into the cytoplasm, the RNP template-associated viral RdRp complex 
performs primary transcription to produce the viral mRNAs from the input template. The 
mRNAs are translated to generate the viral proteins including N, P, and L proteins, which 
then carry out replication of the input viral genome to generate multiple progeny genomes. 
The newly synthesized negative-sense RNPs then undergo secondary transcription which 
amplifies the amount of viral mRNAs and proteins for further rounds of replication. 
Cyclophilin A (CypA), a chaperone protein possessing peptidyl cis-trans prolyl-isomerase 
activity, is required for primary transcription of VSVNJ genome but not the VSVI genome. 
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The enzymatic activity of CypA appears to be important, since its inhibition by cyclosporine 
A results in inhibition of primary transcription of VSVNJ by 85-90%.
35 
Biochemical and 
mutational studies have shown that the viral RdRp involved in transcription is distinct 
from that involved in genome replication. Two distinct RdRp complexes have been isolated 
from infected cells and characterized. One complex, comprising of the viral L and P proteins 
along with the cellular guanylyltransferase, translation elongation factor 1α, and heat 
shock protein 60, was found to exclusively synthesize mRNAs and is thus called the viral 
transcriptase. The other complex, comprising of the viral L, P, and N proteins, synthesizes 
only the full- length encapsidated replication products and is termed the viral replicase.
36 
Although the exact role of the cellular proteins in viral transcriptase complex is not known, 
they may facilitate viral transcription. Further studies are required to understand their role 
in VSV transcription. 
VSV mRNAs, like most eukaryotic mRNAs, are capped, methylated, and polyadenylated 
and these modifications are carried out by the viral RdRp (see chapter 5 for further 
details). Methylation of VSV mRNAs to form 5'-terminal structures is required for efficient 
translation in infected cells. Capping of the nascent transcripts is also important for 
transcription elongation and failure of correct 5’ capping results in abortive transcription.
37 
VSV RdRp executes the capping reaction differently by adding GDP instead of GMP (as 
seen in eukaryotic capping) to the viral mRNAs but not to the Le RNA.
38 
Whether this 
unique mechanism of capping of the mRNAs by the viral RdRp is regulated by cellular 
and/or viral factors is not known but is of interest for identifying specific targets for 
therapeutic development. 
Phosphorylation by cellular protein kinases plays important roles in VSV infection 
not only during virus entry but also for viral gene expression. This was demonstrated 
by the effects on viral growth when the overall levels of protein phosphorylation were 
either enhanced or inhibited.
28,39 
The VSV P protein is a multifunctional protein that is 
phosphorylated by cellular kinase(s) for its function in viral genome transcription and 
replication.
40-43 
Although casein kinase II (CKII), a serine/threonine kinase, has been 
identified as one of the kinases involved in phosphorylation of P protein,
44-46 
other kinases 
may also be involved as demonstrated by the use of inhibitors that do not affect CKII 
but block VSV RNA synthesis significantly.
39 
With the recent identification of a tyrosine 
phosphorylation site in the P protein,
47 
it is possible that other cellular kinase(s) may also 
mediate P phosphorylation for transcription and replication. 
Viral Protein Synthesis 
VSV mRNAs are translated in a cap-dependent manner by the host cells translation 
machinery. In the face of ongoing cellular mRNA translation, VSV usurps the translation 
machinery to preferentially translate its mRNAs via multiple mechanisms. The cellular 
eIF4F is a multisubunit complex involved in cap-dependent translation of host mRNAs. 
eIF4F regulates host translation through phosphorylation of cap-binding protein eIF4E, 
a subunit of the eIF4F complex. VSV infection leads to dephosphorylation of eIF4E and 
the translation inhibitor 4E-BP1 (eIF4E- binding protein 1), resulting in lower levels of 
eIF4F complex. Although the mechanism(s) by which VSV mediates these modifications 
is unknown at this time, this strategy allows the virus to subvert the cellular translation 
machinery for preferential translation of the viral mRNAs.
48 
In addition, it appears that the 
cellular site of the transcription also contribute to the fate of the transcripts. Nascent viral 
mRNAs made in the cytoplasm are preferentially translated while translation of the host 
mRNAs is inhibited during VSV infection.
49,50 
    Host Cell Functions in Vesicular Stomatits Virus Replication 5
VSV mRNA synthesis occurs throughout the host cell cytoplasm
51,52 
in inclusion bodies 
that contain the viral RNA synthesis machinery.
52 
The mRNAs are transported from the 
inclusion bodies in a microtubule- dependent manner to the sites of translation.
52 
VSV 
mRNAs do not contain cis-acting sequences that influence translation but they do contain 
cis-acting sequence-independent structural elements, which enhance translation efficiency 
of the viral mRNAs.
50 
These structural elements may be utilized by cellular large ribosomal 
subunit protein rpL40 to facilitate formation of 80S ribosome on VSV mRNAs for 
translation.
53 
rpL40 is required for cap-dependent translation of VSV, measles, and rabies 
virus mRNAs but not for cellular cap-dependent or internal ribosome entry site-driven 
mRNA translation. Thus, rpL40 is a host ribosomal protein that facilitates translation of 
mRNAs of several members of Mononegavirales, including VSV. 
Another mechanism by which VSV mRNAs are preferentially translated is by global 
shutdown of host transcription and translation through the viral M protein. The M protein 
interacts with the nuclear export pathway proteins Rae1 and Nup98 and thereby blocks 
the export of nascent cellular transcripts from the nucleus to the cytoplasm, resulting 
in shutoff of host protein synthesis.
54,55 
Recent studies support a model in which the 
VSV M-Rae1 complexes allow interaction of the M protein with factors involved in 
transcription,
56 
resulting in inhibition of cellular transcription. During VSV infection, 
inactivation of the basal transcription initiation factor TFIID leading to downregulation of 
the host RNA polymerase II activity has been observed,
57 
although detailed mechanisms 
are yet to be uncovered. The possibility that the M protein dismantles TFIID by targeting 
the phosphorylation or the function of TATA-binding protein of TFIID complex has been 
implicated.
58 
Viral Genome Replication 
VSV genome replication is carried out by the viral replicase complex, which is primarily 
composed of the P and L proteins. Recent studies have identified various host factors 
that positively influence viral genome replication. The chaperone protein HSP90AB1
59 
was found to enhance the stability of VSV RdRp polymerase while cytoskeleton protein 
tubulin
60 
may associate with VSV L protein thereby facilitating viral genome replication. 
Studies have also implicated a role for the cellular La protein in VSV RNA replication. 
The La protein, which is normally associated with the pol III transcripts, was also shown 
to be specifically associated with the plus-strand and longest minus-strand (54 nt) leader 
RNAs in VSV-infected cells.
61,62 
The association correlated with enhancement in genome 
replication but the exact role of La protein, if any, remains to be deciphered. 
Host Functions in VSV Assembly and Budding 
VSV assembly occurs at the plasma membrane and is mediated by the viral M and G 
proteins. Current evidences indicate that VSV RNA and the individual proteins are 
transported to the plasma membrane via different routes. The G protein is synthesized in 
association with the ER where it is glycosylated and transported to the Golgi apparatus for 
processing of the glycan moieties and is finally transported to the plasma membrane. The 
cellular secretory pathway is used for transport of G protein to the plasma membrane,
63 
where it forms membrane microdomains
64 
important for VSV budding. In addition to the 
role played by coatomer protein complex II (COPII) and COPI in VSV G protein transport
65 
(see section 5.1 below), the maturation and transport of VSV G protein also requires the 
presence of the trafficking protein particle complex subunit 3 (Bet3),
66 
which functions 
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downstream of COPII and upstream of Rab1, alpha-SNAP and the EGTA-sensitive stage 
during the ER-Golgi transport. The vesicle-trafficking protein SEC22b, which functions at 
the level of the intermediate compartment (IC) in ER- Golgi transport, is also required.
67 
VSV M is a soluble protein and is brought to the plasma membrane by an unknown 
mechanism, but the association of M protein with the plasma membrane results in 
formation of microdomains, which is independent of the G protein.
68 
The viral NC, with 
the associated polymerase complex is assembled in the cytoplasm and is then transported 
to the plasma membrane in a microtubule dependent manner
51 
where it associates with M 
protein.
69 
After assembly, virus budding and release continue to depend on the function of the 
M protein and its cellular interacting partners. The N terminal region, especially the 
amino acid 17-33 of M protein contains a PPxY motif that interacts with WW (tryptophan) 
domains of cellular proteins such as Yes-kinase associated protein (YAP) to recruit them to 
the site of virus budding.
70,71 
Additionally, the interaction between M protein and dynamin 
1 and 2 also promotes viral assembly and budding.
72 
Since enveloped virus budding and 
release is considered to be topologically equivalent to MVB biogenesis,
73,74 
several of the 
factors including the ESCRT machinery are also required for VSV budding and release. 
Although the tumor susceptibility gene 101 protein (TSG101), a member of the ESCRT-I 
machinery appears to be dispensable for VSV budding,
75 
the role of vacuolar protein 
sorting-associated protein 4A (VPS4A), an AAA+ ATPase required for disassembly and 
recycling of ESCRT components,
76 
remains somewhat unresolved. In one study, the use of 
dominant negative VPS4A mutant showed that VPS4A is not essential for VSV budding;
75 
however in a separate study, dominant negative forms of both VPS4A and 4B were shown 
to inhibit VSV budding.
77 
Nevertheless, the ESCRT machinery is required for scission of 
the viral membrane from the plasma membrane during budding (see chapter 8 for further 
details). In addition, the proteasomal pathway has been found to be indispensable for the 
virus budding.
77-79 
The lipid composition of the membrane bilayer and lipid biogenesis 
may also play certain roles in the binding of M protein to the host cell membrane, since it 
was shown that triacylglycerol synthesis might interfere with virus maturation.
80 
A recent 
mass-spec analysis of virion-associated proteins revealed a number of cellular proteins 
including integrin β1, HSP90, HSP cognate 71, annexin 2, EEF1A1 to have been packaged 
in the VSV virions.
81 
These cellular proteins may potentially be involved in virus assembly, 
budding, and/or in other stages of virus infection processes. Functional studies of these 
proteins will be required to understand and appreciate their role in VSV life cycle. 
Cellular Pathways that Regulate VSV Infection 
In the previous sections, we described the role(s) of many individual host factors that 
facilitate or restrict VSV replication at various stages. Many of these factors appear to be 
involved in multiple steps of the viral life cycle. Cross-talk between various host factors 
and the pathways they represent also seems to be important for efficient multiplication or 
efficient restriction of replication of the virus. In several chapters of this book, the role(s) of 
many of these pathways in VSV infection have been described and the reader is directed to 
those chapters for further details. Although the list of factors and pathways that regulate 
VSV infection is by no means complete and will likely grow in the future, we describe below 
several of the major pathways and the associated factors that influence VSV replication. 
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Endocytic and Secretory Pathways 
As described above (section 2.2), factors associated in CME are required for entry of VSV. 
The host proteins in the endocytic pathway and their roles in viral entry and nucleocapsid 
uncoating have been described in greater detail in chapter 3. 
The secretory pathway plays a critical role in VSV replication cycle. This pathway 
involves anterograde and retrograde transport of proteins and lipids, which are mediated 
by vesicles containing distinct sets of cytosolic coat protein complexes, the (COPII) and 
(COPI), respectively.
82,83 
Early studies revealed that the transport of VSV G from its site of 
synthesis in the ER to the Golgi and finally to the plasma membrane requires both COPII 
and COPI.
65 
In these studies, the newly synthesized G protein was found to accumulate in 
COPII-containing vesicles at the ER, which then fuse to form larger transport complexes or 
ICs. In these ICs, the COPII is then replaced by COPI and the vesicles are then transported 
to the Golgi complex in a microtubule-dependent manner, thus suggesting a sequential 
mode of action of these two coatomer protein complexes in VSV G protein transport.
65 
In addition to its role in G protein transport, the secretory pathway and, in particular, the 
COPI, also appears to play an important role in VSV gene expression.
84 
The observations 
that (i)VSV gene expression is inhibited in COPI-depleted cells that are independent of 
the viral G protein processing and transport, (ii) pharmacologic inhibitors of COPI inhibit 
VSV gene expression as well as reduce viral RNA levels, (iii) viral gene expression requires 
the ADP ribosylation factor 1 (ARF1) and the Golgi-associated brefeldin A resistant factor 
1 (GBF1), the two upstream effectors of COPI function, and (iv) VSV gene expression is 
reduced in nucleocapsid transfected cells that have been depleted of COPI strongly suggest 
a role for COPI function in viral RNA synthesis.
84 
Additional evidence for the involvement 
of COPI in VSV RNA synthesis comes from studies using cells having a temperature-
sensitive _-COP, a subunit of the heptameric COPI complex.
85 
Mechanistically, whether the 
COPI complex is directly involved in regulating the viral polymerase functions or whether 
it may signal through downstream effectors essential for viral gene expression is not known 
at this time. VSV replicates throughout the cytoplasm of infected cells,
51,52 
although the 
existence of specific replication organelles in the cytoplasm whose assembly requires COPI 
function cannot be ruled out. The requirement of COPI for genome replication has been 
well documented for positive- strand RNA viruses, which replicate in association with 
cytoplasmic membranous structures.
86 
Further biochemical and ultrastructural studies in 
cells infected with VSV will likely illuminate the nature of the replication organelles, if any, 
for these viruses. 
Innate Immune Signaling Pathways 
Host cells survey invasive RNA viruses including VSV by the viral ssRNA, dsRNA 
or glycoproteins using either membrane-associated or cytosolic pattern recognition 
receptors (PRRs) to mount a well- orchestrated innate immune defense (see chapter 15 
for further details). The membranous PRRs like toll-like receptor 4 (TLR4) present at the 
plasma membrane as well as TLR3, TLR7 and TLR8 in the endosomes, recognize the 
VSV glycoprotein (VSV-G) or RNA and transduce downstream antiviral signaling that 
culminates in the activation of transcription factors such as IFN regulatory factors 3 (IRF3), 
IRF7, IRF5 and/or nuclear factor κB (NF-κB),
87,88 
leading to the production of IFN and 
proinflammatory cytokines by the infected cells. Recently, TLR13, a novel member of the 
mammalian TLR family was reported to activate type I IFN production via activation of NF-
κB and IRF7.
89 
TLR13 seems to detect VSV at the surface of dendritic cells, macrophages or 
cells of the spleen where it is predominantly expressed. VSV RNP contributes to the early 
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recognition of infection by the cytoplasmic PRRs consisting of the retinoic-acid-inducible 
gene I (RIG-I) and the melanoma differentiation-associated protein 5 (MDA5). RIG-I plays 
a major role in sensing VSV infection, since type I IFN production was found to be severely 
impaired in VSV infected RIG-I
-/- 
MEFs compared to wild-type cells whereas MDA5 was 
dispensable.
90 
PRR signaling results in production and secretion of IFN-α/β, which in autocrine 
or paracrine fashion, activate the JAK-STAT signaling pathway leading to synthesis of 
hundreds of interferon stimulated gene (ISG) products. Many ISGs, such as, phospholipase 
C (PLC) and phospholipase A2 (PLA2),
91 
guanylate binding protein-1 (GBP-1),
92 
and Mx1
93 
are well-known for their antiviral effects against VSV, but the mechanism(s) of their action 
is poorly understood. A recent functional ISG screen documented 34 ISGs showing antiviral 
activity against VSV; included among them are novel ISGs such as ISG20, IFITM3, OAS1, 
MGA T1, GPR146, P ARP12, L Y6E, APOBEC proteins.
94 
ISGs antagonize various stages of the 
VSV life cycle. The enzyme, cholesterol-25-hydroxylase, generates 25-hydroxycholesterol 
(25HC) which then suppresses VSV and several other enveloped virus infections by 
blocking the membrane fusion step.
95 
IFITM3 disrupts an early event after endocytosis 
but before primary transcription,
96 
whereas the viral primary transcription step is blocked 
by poly (C) binding proteins 2 (PCBP2).
97 
Viral genome transcription and replication are 
efficiently blocked by 2',5'-oligoadenylate (2-5As) and 2-5As synthetases (OASs). One of 
the well-characterized inhibitors of VSV translation is the double- stranded RNA-activated 
protein kinase (PKR).
98 
PKR modulates the inhibitory effect through multiple mechanisms, 
the most prominent being the phosphorylation of the eukaryotic translation initiation factor 
2α (eIF2α) and subsequent shutoff of host and viral translation.
99 
The other mechanism 
involves phosphorylation of nuclear factor associated with dsRNA 1 and 2 (NFAR1/2) 
protein, which is then retained on the ribosomes, associates with viral transcripts and 
thereby sequesters viral mRNA from being translated.
100 
Other ISGs suppress VSV growth 
at translation and replication steps. The promyelocytic leukemia (PML) protein interferes 
with VSV mRNA synthesis, protein synthesis, and contribute to the antiviral state induced 
in mice infected with VSV.
101, 102 
This antiviral effect requires PML SUMOylation.
103 
The 
final step in the VSV life cycle, virus budding, is inhibited by tetherin, which blocks virion 
particle release from infected cells.
96 
Contrary to the classical function of ISGs as antiviral effectors, many ISGs also 
play a negative regulatory role to prevent excessive IFN production. A number of ISGs 
such as ISG56 and gC1qR negatively regulate the VSV antiviral response by interfering 
with interactions of the STING/MITA, IPS-1/VISA, and TBK1,
104,105 
whereas other ISGs 
such as TRIAD3a, TRAF induce degradation of TRAF3 and TBK1, respectively.
106,107 
Recently, studies from our laboratory identified the interferon inducible protein IFI35 as a 
negative regulator of RIG-I antiviral responses during VSV infection.
108 
IFI35 was found 
to interact with RIG-I and the RIG-I activity was attenuated through maintenance of its 
inactive, phosphorylated form and also through degradation of RIG-I by K-48-linked 
ubiquitination.
108 
It appears that an intricate balance between the activities of various ISGs 
during VSV infection may modulate the outcome of the infection, although additional 
factors may also be involved. 
In recent years, autophagy has emerged as an important pathway complementing 
the innate immune pathways. Autophagy is an evolutionarily conserved mechanism 
in eukaryotes for degradation of unwanted intracellular cargo. Studies have shown 
autophagy to play an antiviral or proviral role depending on the virus and the host cell 
type.
109 
For VSV, autophagy plays an antiviral role in the Drosophila model.
110 
Recent 
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studies have demonstrated that VSV infection induces autophagy in Drosophila cells via 
TLR-7-mediated recognition of VSV G protein from replication-competent VSV , UV 
inactivated (replication- incompetent) VSV or VSV-G harboring virus like particles (VLPs), 
suggesting the VSV G protein as the pathogen associated molecular pattern (PAMP) that 
stimulates the autophagy pathway. Interestingly, the AKT-mTOR axis involved in nutrient 
signaling also plays a role in activating the antiviral autophagy program.
111 
In contrast, 
many positive sense RNA viruses like Dengue, Hepatitis C virus (HCV) and some DNA 
viruses like Kaposi sarcoma herpesvirus (KSHV) have been found to utilize autophagy 
as a proviral mechanism, which makes this pathway a necessary evil for the host in these 
cases.
109 
Apoptotic and Cell Survival Pathways 
VSV infection initiates both intrinsic (mitochondrial) apoptosis through caspase-9
112 
and 
extrinsic apoptosis through PKR, DAXX, and partly via Fas and caspase-8
113 
(see chapter 
7 for further details). Apoptosis can occur at an early stage of VSV life cycle without a 
requirement for RNA replication.
114 
The apoptotic consequence is thought to be primarily 
due to viral M protein and leader RNA
115,116 
in addition to the alteration of levels of proteins 
in apoptotic pathways.
117,118 
The molecular mechanism for IFN to regulate VSV induced 
apoptosis is not clear yet but several signaling factors including STAT,
119,120 
the ISGs such 
as PKR and OAS
121,122 
and the apoptosis-inducing factor p53
123 
appear to be involved. 
In addition, cross-talk between apoptosis and innate immune response in VSV infection 
is responsible for induction of the intrinsic apoptotic pathway involving Bax-Caspase-9, 
which triggers phosphorylation of IRF3 and downstream type I IFN production.
124 
Initiation of apoptosis by VSV M protein requires cellular factors and is cell-type 
dependent. Wt VSV induces faster apoptosis in HeLa cells than the mutant VSVM51R 
virus but it is the reverse in BHK-21 cells.
125 
Consistent with this observation, we recently 
demonstrated a role for hnRNP K in supporting VSV infection through suppressing 
apoptosis induction and promoting survival of infected cells.
117 
The studies revealed that 
hnRNP K helps maintain the low levels of expression of proapoptotic proteins such as 
BiK and Bcl-XS and high levels of expression of antiapoptotic proteins such as Bcl-XL, 
Bag1, and Bcl-2.
117 
Additionally, hnRNP K supports expression of several cellular factors 
required for VSV replication and negatively regulates expression of cellular factors known 
to inhibit VSV replication. In particular, hnRNP K suppresses overall levels of total T-cell 
intracellular antigen 1 (TIA1) as well as expression of the TIA1b isoform (a differentially 
spliced form of TIA1a); both isoforms of TIA1 suppress VSV replication.
117,126 
Studies of 
the hnRNP K interactome revealed more than 100 interacting partners and determined 
that hnRNP K protein is present in the nucleus, cytoplasm, mitochondria, and the vicinity 
of the plasma membrane.
127 
Thus, it is possible that hnRNP K exerts its positive impact on 
VSV growth through one or more of its interacting partners and may be involved in cross-
talk between multiple pathways required for efficient VSV replication. The requirement of 
hnRNP K in VSV replication and the observation that hnRNP K levels in many cancerous 
cell types is upregulated may add to the understanding of why tumor cells provide an 
appropriate microenvironment (in addition to defective type I IFN response and signaling) 
for efficient VSV growth. 
In contrast to the function of hnRNP K, hnRNPA1 plays a supporting role in VSV 
mediated apoptosis.
128 
Studies have shown that VSV infection leads to a decrease of other 
antiapoptotic proteins such as keratinocyte transcription factor TP63
129 
and myeloid cell 
leukemia 1 protein (Mcl-1),
130 
while proapoptotic Bax was increased in the immortalized 
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HaCaT keratinocyte cell line.
129 
miR-706 is upregulated in VSV infection and is able to 
inhibit VSV-induced apoptosis by decreasing caspase-3 and -9 activation, suggesting that 
induction of miR- 706 expression may be a novel strategy for survival of VSV, allowing it 
to escape the apoptosis response of the host.
131 
Akt/phosphatidylinositol-3-kinase (PI3K) pathway is a major cellular pathway 
controlling cell growth, proliferation, translation, and suppression of apoptosis. A variety 
of viruses are known to modulate this pathway. The observations that treatment of cells 
with Akt inhibitors significantly reduced VSV growth
132 
and constitutively active Akt 
enhanced VSV replication
133 
suggest that the Akt pathway is important in VSV replication. 
However, conflicting data also exist as to the role of this pathway in viral replication. Akt 
is activated in macrophages infected with VSV and this leads to the inhibition of virus 
replication.
134 
Similarly, inactivation of Akt also favors VSV replication in BHK-21 cells.
135 
On the other hand, downregulation of Akt in Drosophila suppresses VSV replication.
110 
RNA Interference (RNAi) Pathway 
The cellular RNA interference (RNAi) pathway, which is an innate immune defense 
mechanism to control viral infections in plants and insects, is also involved in regulating 
VSV infection. This was first demonstrated in the worm Caenorhabditis elegans.
136,137 
Cells 
derived from mutant worms defective in the RNAi response supported higher levels of 
VSV replication as compared to the cells from the wild-type counterpart indicating that the 
RNAi pathway controls replication of VSV.
136,137 
In Drosophila, RNAi-mediated response 
also confers protection against infection by VSV.
138,139 
Depletion of the arsenite resistance 
protein 2 (Ars2), which is required for siRNA- and miRNA- mediated silencing, results 
in increased replication of VSV in Drosophila cell cultures and adult flies.
139 
The RNAi 
pathway has been shown to be inducible by IFN
140 
and thus constitutes another arm of 
the innate host defense against a variety of virus infections in vitro
141 
and in vivo.
142 
Mice 
hypomorphic for Dicer, the endoribonuclease that catalyzes production of siRNAs and 
miRNAs, are more sensitive to VSV infection due to impairment in production of miR24 
and miR93,
143 
highlighting an important role for miRNAs in antiviral defense against VSV 
in mammalian systems. The miR93 and miR24 target the viral mRNAs for the P and L 
proteins, respectively, and thus suppress VSV replication. The cellular RNAi pathway also 
participates in controlling the appropriate response of innate immunity to VSV infection. 
Some miRNAs such as miR-146a and miR-466l negatively regulate type I IFN responses and 
support VSV infection.
144,145 
Thus, the important role of the RNAi pathway in regulating 
VSV replication is being increasingly appreciated. 
ESCRT Pathway 
The ESCRT pathway is intimately involved in steps during virus entry as well in virus 
assembly and exit from the cells. The specific role(s) of various ESCRT subunits in the VSV 
life cycle has been detailed in chapters 3 and 8. 
Stress Response Pathway 
The crosstalk between stress induced responses and cellular innate immunity has been 
established in cellular responses to suppress VSV infection. It is known that VSV infection 
induces both oxidative stress and an anti-oxidative response in mammalian cells.
146 
Stressful conditions such as viral infections, hypoxia, heat shock, UV irradiation, amino 
acid starvation or oxidative stresses induced by arsenite treatment can activate one or more 
of the five putative eIF2α kinases (PERK, GCN2, PKR, HRI and Z-DNA kinases). eIF2α 
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phosphorylation results in global shutoff of cap-dependent translation with the exception 
of proteins belonging to the stress response pathway, such as heat shock proteins.
147,148 
Stress-induced Growth Arrest and DNA Damage- inducible protein 34 (GADD34) is 
induced by VSV infection.
133 
It suppresses viral replication by inhibiting the mTOR 
pathway,
133 
which is required for viral protein synthesis. These studies indicate that the 
stress- inducible response plays a critical role in antiviral defense against VSV. In addition, 
hypoxia-inducible factor (HIF) plays an antiviral role in VSV infection by upregulating 
type I IFN and ISGs production.
149 
A functional proteasome pathway also seems to be important for VSV protein 
synthesis since proteasome inhibitors significantly suppress viral protein synthesis 
through stimulation of stress-related responses such as phosphorylation of eIF2α.
150 
The 
host protein, REgulated in Development and DNA Damage responses 1 (REDD1), which 
is usually induced in cells undergoing ER stress,
151 
is initially induced at early stages 
of VSV infection but quickly decreases back to normal levels at 4 hpi due to the global 
suppression of translation by VSV M protein.
152 
The demonstration of antiviral activity by 
the small molecules, nephthalimides, through upregulation of REDD1 and concomitant 
inhihition of mTORC1 suggest that mTORC1 plays an important role in regulation of VSV 
replication. The requirement for activation of mTORC1 for VSV infection appears to be 
for viral mRNA translation.
152 
In addition to its role in translational control, mTORC1 is 
known to stimulate type I IFN production through phosphorylation of p70S6K and 4E-
BP1.
153,154 
These findings suggest that exploitation of mTORC1 pathway may be another 
mechanism that VSV employs to facilitate viral mRNAs translation. However, the 
apparent paradoxical effects of mTORC1 activation on stimulation of IFN production and 
upregulation of VSV replication needs further investigation to help clarify and determine 
the mechanistic involvement of mTORC1 in VSV replication. 
Other Factors and Pathways 
Post-translational modifications such as glycosylation, phosphorylation, ubiquitination, 
SUMOylation, ISGylation, etc, affect the maturation of viral proteins and thus regulate VSV 
replication. These modifications also influence activities of many host cell proteins that 
regulate VSV infection. Prostaglandin A1 (PGA1) and the delta12-Prostaglandin J2 (delta 
12-PGJ2), a naturally occurring dehydration product of prostaglandin D2, inhibit VSV 
growth via suppression of synthesis and post-translational glycosylation of G protein.
155,156 
The activity of VSV P and M proteins are also affected by type I IFN in neuronal cells, 
whereP is hypophosphorylated and M is hyperphosphorylated. Hypophosphorylated P 
may affect VSV replication and transcription
40-43 
whereas hyperphosphorylated VSV M 
protein inhibits its association with VSV nucleocapsid.
157 
These studies suggest a possible 
mechanism for type I IFN-mediated misassembly through disruption of the interactions 
between viral RNP and the M protein.
157 
The VSV M is ubiquitinated by Rsp5 ubiquitin 
ligase and thus may play a role in virus assembly and budding.
78 
The hnRNPU, a protein involved in pre-mRNA processing, specifically interacts 
with the VSV leader RNA in the nuclei and colocalizes with the viral RNP in the cytoplasm. 
hnRNPU is also packaged within purified VSV virions
158 
but its role in the viral life cycle 
remains to be examined. In contrast, PCBP1 and PCBP2, cellular regulators of splicing, 
transcription, translation, and mRNA stability, interact with VSV P and function as negative 
regulators of virus gene expression.
97 
Further studies reveal that TIA1, a PCBP2-interacting 
partner and a critical factor for stress granule formation,
147,159 
also functions as a negative 
regulator of VSV gene expression.
126 
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 The PI3K/Akt/NF-κB pathway requires the presence of Grb2- associated binder 
1 (Gab1), a member of scaffolding/adaptor proteins, to protect macrophages from VSV 
infection.
160 
Akt1 phosphorylates and inactivates the transcription repressor EMSY, 
resulting in its inability to bind to ISG promoters, leading to the expression of ISGs and 
inhibition of VSV growth.
161 
The protein arginine N-methyltransferase (PRMT1) specifically 
binds to the intracytoplasmic domain of the type I IFN receptor to transduce the antiviral 
signaling mediated by IFN-β.
162 
The involvement of PKC in the antiviral response to 
VSV infection mediated by hormone oxytoxin in human amnion cells
163 
and by cAMP in 
macrophages
164 
has been noted. On the other hand, the tyrosine receptor kinase (TRK)-
fused gene (TFG) protein plays a supportive role in VSV infection by negatively regulating 
the RIG-I/MAVS/NF-κB axis of antiviral signaling.
165 
Other factors, such as, HSP70 facilitates type I IFN-dependent antiviral immunity 
against VSV in neurons,
166 
whereas Cancer Upregulated Gene 2 (CUG2), a novel oncogene, 
makes cells resistant to VSV through the activation of STAT1-ISGs signaling.
167 
In addition 
to type I IFN, type II and type III IFNs antagonize VSV infection and replication. Type 
III IFNs (IFN-λ1, -λ2, and -λ3) are induced during VSV infection
168 
and mediate antiviral 
responses similar to type I IFN. IFN-λ1 is more effective than the other two members. 
IFN-γ inhibits VSV infection
169,170 
through inhibition of VSV protein synthesis as a result 
of upregulation of NOS-1 and increased NO production in neuronal cells.
171 
In cells of the 
reticuloendothelial system, IFN-γ treatment induces the expression of a set of low molecular 
weight MHC- encoded proteins (LMPs), which replace the beta-subunit of the proteasome 
complex during the proteasome neosynthesis, resulting in an antiviral complex termed the 
immunoproteasome in neuronal cells
171 
that restricts VSV replication. 
Concluding Remarks and Future Perspectives 
VSV requires many cellular factors and pathways for efficient replication in host cells. 
Likewise, the host cells respond to VSV infection by expressing and/or activating factors 
and pathways to restrict virus replication. It is the net effect of these opposing factors/
pathways that likely determines the outcome of the virus infection. As discussed above, 
mechanistic understanding of many factors that regulate VSV infection has been achieved; 
however, our current understanding of the role(s) of many others remains elusive. At this 
time, two genome-wide siRNA screens,
84,172 
a kinome screen for the endocytic pathway
29 
and at least two antiviral small molecule screens
152,173 
have revealed many interesting 
cellular factors that regulate VSV infection at multiple stages in the viral life cycle (Fig. 
1). Understanding of the role(s) of these proteins and cross-talk between them and the 
cellular pathways involved in the VSV life cycle is of paramount significance for a better 
understanding of VSV-host cell interactions. VSV is not only used as a model pathogen 
for understanding the mechanisms of replication and pathogenesis of this class of viruses, 
it is also used as a vaccine vector and an oncotherapeutic agent. Therefore, a complete 
understanding of VSV-host interactions will also be crucial for development of more 
efficacious vaccine vectors and oncolytic VSV. 
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